GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heart Test Laboratories Inc (NAS:HSCS) » Definitions » Earnings per Share (Diluted)

Heart Test Laboratories (Heart Test Laboratories) Earnings per Share (Diluted) : $-48.00 (TTM As of Jan. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Heart Test Laboratories Earnings per Share (Diluted)?

Heart Test Laboratories's Earnings per Share (Diluted) for the three months ended in Jan. 2024 was $-3.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was $-48.00.

Heart Test Laboratories's EPS (Basic) for the three months ended in Jan. 2024 was $-3.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 was $-48.00.

Heart Test Laboratories's EPS without NRI for the three months ended in Jan. 2024 was $-3.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2024 was $-48.00.

During the past 3 years, the average EPS without NRIGrowth Rate was -19.20% per year.

During the past 4 years, Heart Test Laboratories's highest 3-Year average EPS without NRI Growth Rate was -19.20% per year. The lowest was -19.20% per year. And the median was -19.20% per year.


Heart Test Laboratories Earnings per Share (Diluted) Historical Data

The historical data trend for Heart Test Laboratories's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heart Test Laboratories Earnings per Share (Diluted) Chart

Heart Test Laboratories Annual Data
Trend Apr20 Apr21 Apr22 Apr23
Earnings per Share (Diluted)
-47.39 -30.49 -59.52 -80.00

Heart Test Laboratories Quarterly Data
Apr20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.00 -16.00 -13.00 -16.00 -3.00

Competitive Comparison of Heart Test Laboratories's Earnings per Share (Diluted)

For the Medical Devices subindustry, Heart Test Laboratories's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heart Test Laboratories's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Heart Test Laboratories's PE Ratio distribution charts can be found below:

* The bar in red indicates where Heart Test Laboratories's PE Ratio falls into.



Heart Test Laboratories Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Heart Test Laboratories's Earnings Per Share (Diluted) for the fiscal year that ended in Apr. 2023 is calculated as

Diluted Earnings Per Share (A: Apr. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-6.354-0)/0.080
=-79.43

Heart Test Laboratories's Earnings Per Share (Diluted) for the quarter that ended in Jan. 2024 is calculated as

Diluted Earnings Per Share (Q: Jan. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-1.644-0)/0.538
=-3.06

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-48.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Heart Test Laboratories  (NAS:HSCS) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Heart Test Laboratories Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Heart Test Laboratories's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Heart Test Laboratories (Heart Test Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
Executives
David R. Wells director 2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent director 750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz director, officer: See Remarks 3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson director, officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092